Elanco Animal Health (ELAN) Competitors $9.74 +0.28 (+2.90%) Closing price 05/2/2025 03:59 PM EasternExtended Trading$9.70 -0.05 (-0.51%) As of 05/2/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ELAN vs. SMMT, TEVA, ITCI, GMAB, RDY, MRNA, ASND, VTRS, QGEN, and ROIVShould you be buying Elanco Animal Health stock or one of its competitors? The main competitors of Elanco Animal Health include Summit Therapeutics (SMMT), Teva Pharmaceutical Industries (TEVA), Intra-Cellular Therapies (ITCI), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Moderna (MRNA), Ascendis Pharma A/S (ASND), Viatris (VTRS), Qiagen (QGEN), and Roivant Sciences (ROIV). These companies are all part of the "pharmaceutical products" industry. Elanco Animal Health vs. Summit Therapeutics Teva Pharmaceutical Industries Intra-Cellular Therapies Genmab A/S Dr. Reddy's Laboratories Moderna Ascendis Pharma A/S Viatris Qiagen Roivant Sciences Summit Therapeutics (NASDAQ:SMMT) and Elanco Animal Health (NYSE:ELAN) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings, community ranking, media sentiment and institutional ownership. Which has more volatility & risk, SMMT or ELAN? Summit Therapeutics has a beta of -0.46, indicating that its share price is 146% less volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.44, indicating that its share price is 44% more volatile than the S&P 500. Which has better valuation & earnings, SMMT or ELAN? Summit Therapeutics has higher earnings, but lower revenue than Elanco Animal Health. Summit Therapeutics is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSummit Therapeutics$700K29,401.82-$614.93M-$0.31-90.00Elanco Animal Health$4.44B1.09-$1.23B$0.6714.54 Do insiders & institutionals believe in SMMT or ELAN? 4.6% of Summit Therapeutics shares are owned by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are owned by institutional investors. 88.3% of Summit Therapeutics shares are owned by insiders. Comparatively, 0.9% of Elanco Animal Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media refer more to SMMT or ELAN? In the previous week, Summit Therapeutics had 7 more articles in the media than Elanco Animal Health. MarketBeat recorded 23 mentions for Summit Therapeutics and 16 mentions for Elanco Animal Health. Elanco Animal Health's average media sentiment score of 1.03 beat Summit Therapeutics' score of 0.91 indicating that Elanco Animal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Summit Therapeutics 10 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Elanco Animal Health 14 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is SMMT or ELAN more profitable? Elanco Animal Health has a net margin of 4.60% compared to Summit Therapeutics' net margin of 0.00%. Elanco Animal Health's return on equity of 6.78% beat Summit Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Summit TherapeuticsN/A -85.42% -52.66% Elanco Animal Health 4.60%6.78%3.03% Does the MarketBeat Community favor SMMT or ELAN? Summit Therapeutics received 170 more outperform votes than Elanco Animal Health when rated by MarketBeat users. Likewise, 58.65% of users gave Summit Therapeutics an outperform vote while only 54.62% of users gave Elanco Animal Health an outperform vote. CompanyUnderperformOutperformSummit TherapeuticsOutperform Votes31258.65% Underperform Votes22041.35% Elanco Animal HealthOutperform Votes14254.62% Underperform Votes11845.38% Do analysts rate SMMT or ELAN? Summit Therapeutics presently has a consensus price target of $37.40, suggesting a potential upside of 34.05%. Elanco Animal Health has a consensus price target of $14.67, suggesting a potential upside of 50.50%. Given Elanco Animal Health's higher probable upside, analysts plainly believe Elanco Animal Health is more favorable than Summit Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Summit Therapeutics 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 3.00Elanco Animal Health 0 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.43 SummaryElanco Animal Health beats Summit Therapeutics on 10 of the 18 factors compared between the two stocks. Get Elanco Animal Health News Delivered to You Automatically Sign up to receive the latest news and ratings for ELAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELAN vs. The Competition Export to ExcelMetricElanco Animal HealthPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$4.84B$6.85B$5.55B$19.21BDividend YieldN/A2.97%5.09%4.01%P/E Ratio24.367.4722.7133.50Price / Sales1.09258.18405.2729.19Price / Cash4.8465.8538.1817.52Price / Book0.776.566.794.55Net Income-$1.23B$143.41M$3.22B$1.02B7 Day Performance3.12%3.37%3.33%2.29%1 Month Performance0.72%10.31%6.89%2.94%1 Year Performance-27.97%-3.58%16.07%4.67% Elanco Animal Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELANElanco Animal Health4.0761 of 5 stars$9.75+2.9%$14.67+50.5%-27.6%$4.84B$4.44B24.369,800Upcoming EarningsShort Interest ↑Positive NewsGap UpSMMTSummit Therapeutics2.9052 of 5 stars$24.11+2.7%$37.50+55.5%+587.2%$17.79B$700,000.00-86.10110Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap UpHigh Trading VolumeTEVATeva Pharmaceutical Industries3.1444 of 5 stars$15.03+1.1%$23.43+55.9%+15.2%$17.04B$16.54B-10.3736,800Upcoming EarningsAnalyst RevisionNews CoveragePositive NewsGap UpITCIIntra-Cellular Therapies0.9358 of 5 stars$131.87flat$109.70-16.8%N/A$14.05B$680.50M-151.57560Upcoming EarningsAnalyst ForecastGMABGenmab A/S4.4506 of 5 stars$20.63+0.2%$39.17+89.9%-22.5%$13.66B$21.53B11.861,660Upcoming EarningsGap UpRDYDr. Reddy's Laboratories1.7483 of 5 stars$13.95+1.2%$17.00+21.9%-6.4%$11.65B$311.31B22.2124,800Upcoming EarningsPositive NewsMRNAModerna4.3377 of 5 stars$27.46+0.9%$58.70+113.8%-78.0%$10.62B$3.20B-2.963,900Earnings ReportAnalyst ForecastNews CoverageGap UpASNDAscendis Pharma A/S2.3477 of 5 stars$164.88+0.4%$204.67+24.1%+21.9%$10.05B$363.64M-23.22640Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageVTRSViatris1.6056 of 5 stars$8.25+1.5%$10.50+27.3%-25.4%$9.85B$14.74B-11.1537,000Upcoming EarningsGap UpQGENQiagen3.8175 of 5 stars$42.49+1.0%$47.83+12.6%+4.0%$9.45B$1.98B118.316,030Upcoming EarningsNews CoverageGap UpROIVRoivant Sciences2.2507 of 5 stars$11.19+1.6%$17.50+56.4%+2.1%$7.98B$122.59M-74.60860 Related Companies and Tools Related Companies SMMT Competitors TEVA Competitors ITCI Competitors GMAB Competitors RDY Competitors MRNA Competitors ASND Competitors VTRS Competitors QGEN Competitors ROIV Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ELAN) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elanco Animal Health Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Elanco Animal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ELAN Stock Free ELAN Stock Alerts